Tailored Strategy for Locally-Advanced Rectal Carcinoma (GRECCAR 4)

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Philippe Rouanet ◽  
Eric Rullier ◽  
Bernard Lelong ◽  
Philippe Maingon ◽  
Jean-Jacques Tuech ◽  
...  
Keyword(s):  
Rectal Carcinoma ◽  
Locally Advanced

Neoadjuvant Chemotherapy and Radiotherapy in Locally Advanced Rectal Carcinoma

2019 ◽  
Vol 23 (1) ◽  
pp. 221-228
Author(s):  
Mohmed Gaber ◽  
Mohamed Alhashemee ◽  
Al Sayed Hassan ◽  
Sahar Hammam
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Rectal Carcinoma ◽  
Locally Advanced

Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases

2014 ◽  
Vol 65 (5) ◽  
pp. 623-630 ◽  
Author(s):  
Aurélie Sannier ◽  
Jérémie H Lefèvre ◽  
Yves Panis ◽  
Dominique Cazals-Hatem ◽  
Pierre Bedossa ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Rectal Carcinoma ◽  
Locally Advanced ◽  
Neoadjuvant Radiochemotherapy

Concurrent Boost Radiotherapy as Preoperative Treatment for Locally Advanced Rectal Carcinoma: A New Beam Arrangement

2002 ◽  
Vol 88 (4) ◽  
pp. 325-330 ◽  
Author(s):  
Carlo Capirci ◽  
Francesca Valvo ◽  
Simonetta Salviato ◽  
Marcello Gava ◽  
Giovanni Mandoliti ◽  
...  
Keyword(s):  
Rectal Carcinoma ◽  
Locally Advanced ◽  
Patient Positioning ◽  
Radiation Doses ◽  
Preoperative Treatment ◽  
New Device ◽  
Treatment Data ◽  
Target Volumes ◽  
Boost Radiotherapy ◽  
To Receive

Purpose To describe a new beam arrangement for preoperative concurrent boost radiotherapy in locally advanced rectal carcinoma. Material and methods Three different volumes, ie posterior pelvis, total mesorectal space, and gross tumor volume plus 2 cm, are selected to receive radiation doses of 47 Gy, 51 Gy, and 54 Gy, respectively, in 24 fractions. There are two prerequisites for the use of such a radiotherapy schedule: complete displacement of the small bowel outside the boost volume, and horizontal positioning of the rectal long axis. Both conditions can be attained by patient positioning on a new device, the “Up-Down Table” (UDT). The dose gradient between the three volumes is realized with two daily arc rotation fields with an isocenter that is different from the three additional multileaf collimator pelvic fields (postero-anterior + 2 laterolateral). Results The treatment data are reported according to the ICRU 62 criteria. A comparison was made between concurrent arc rotation and concomitant static boost techniques. Conclusion The new beam arrangement, with the use of the UDT, allows to administer different radiation doses to three volumes with different tumor cell density in order to obtain the same probability of local response in all target volumes without increasing the toxicity.

scholarly journals Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Gemma Bruera ◽  
◽  
Antonio Giuliani ◽  
Lucia Romano ◽  
Alessandro Chiominto ◽  
...  
Keyword(s):  
Rectal Carcinoma ◽  
Neuroendocrine Carcinoma ◽  
Locally Advanced ◽  
Complete Response ◽  
Neuroendocrine Cells ◽  
Perineal Pain ◽  
Pathological Examination ◽  
First Line ◽  
Triplet Chemotherapy ◽  
Poorly Differentiated

Abstract Background Neuroendocrine tumors (NETs) are heterogeneous, widely distributed tumors arising from neuroendocrine cells. Gastrointestinal (GI)-NETs are the most common and NETs of the rectum represent 15, 2% of gastrointestinal malignancies. Poorly differentiated neuroendocrine carcinomas of the GI tract are uncommon. We report a rare case of poorly differentiated locally advanced rectal neuroendocrine carcinoma with nodal and a subcutaneous metastasis, with a cytoplasmic staining positive for Synaptophysin and Thyroid Transcription Factor-1. Case presentation A 72-year-old male presented to hospital, due to lumbar, abdominal, perineal pain, and severe constipation. A whole-body computed tomography scan showed a mass of the right lateral wall of the rectum, determining significant reduction of lumen caliber. It also showed a subcutaneous metastasis of the posterior abdominal wall. Patient underwent a multidisciplinary evaluation, diagnostic and therapeutic plan was shared and defined. The pathological examination of rectal biopsy and subcutaneous nodule revealed features consistent with small-cell poorly differentiated neuroendocrine carcinoma. First line medical treatment with triplet chemotherapy and bevacizumab, according to FIr-B/FOx intensive regimen, administered for the first time in this young elderly patient affected by metastatic rectal NEC was highly active and tolerable, as previously reported in metastatic colo-rectal carcinoma (MCRC). A consistent rapid improvement in clinical conditions were observed during treatment. After 6 cycles of treatment, CT scan and endoscopic evaluation showed clinical complete response of rectal mass and lymph nodes; patient underwent curative surgery confirming the pathologic complete response at PFS 9 months. Discussion and conclusions This case report of a locally advanced rectal NEC with an unusual subcutaneous metastasis deserves further investigation of triplet chemotherapy-based intensive regimens in metastatic GEP NEC.

Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma

2007 ◽  
Vol 14 (6) ◽  
pp. 1870-1877 ◽  
Author(s):  
Christopher J. Gannon ◽  
Jonathan S. Zager ◽  
George J. Chang ◽  
Barry W. Feig ◽  
Christopher G. Wood ◽  
...  
Keyword(s):  
Rectal Carcinoma ◽  
Pelvic Exenteration ◽  
Locally Advanced

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma

2001 ◽  
Vol 50 (5) ◽  
pp. 1299-1308 ◽  
Author(s):  
Robert J Myerson ◽  
Vincenzo Valentini ◽  
Elisa H Birnbaum ◽  
Numa Cellini ◽  
Claudio Coco ◽  
...  
Keyword(s):  
Phase I ◽  
Rectal Carcinoma ◽  
Locally Advanced ◽  
Venous Infusion ◽  
Boost Radiotherapy

The role of EGFR in predicting clinical outcome in locally advanced rectal carcinoma treated with neoadjuvant chemoradiation

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9592-9592 ◽  
Author(s):  
S. Mawdsley ◽  
S. Bentzen ◽  
G. Wilson ◽  
R. Glynne-Jones ◽  
F. Daley
Keyword(s):  
Clinical Outcome ◽  
Rectal Carcinoma ◽  
Locally Advanced ◽  
Neoadjuvant Chemoradiation
Sign in / Sign up

Export Citation Format

Share Document